Lynda Coughlan MS, PhD

Lynda Coughlan completed her PhD at Bart’s Cancer Institute working on viral gene therapy for cancer and is now a postdoc at the Jenner Institute. Her post-doctoral work has been on the development of adenoviral vectors for cancer gene therapy and more recently as vaccine vectors for infectious disease. She is currently researching the use of adenoviral vectors as influenza vaccines both pre-clinically and in Phase I clinical trials.

Lynda is an elected member of the British Society for Gene and Cell Therapy and is their Public Engagement Coordinator. She also acts as a public engagement representative for the Jenner Institute. Through these organizations, she has been heavily involved in organizing public engagement events in the Oxford area on the subject of gene and cell therapy as well as vaccines and infectious diseases.